MicroRNA-4497 Is Downregulated in Pediatric Allergic Diseases and Suppresses Th2 Inflammation in an Animal Model
International Archives of Allergy and Immunology · 2025
DOI: 10.1159/000545289 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Archives of Allergy and Immunology, 2025. Verfasst von Young Yoo und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pediatrics, Korea University College of Medicine, Seoul, Republic of Korea. Hauptthemen laut MEDLINE: MicroRNAs, Th2 Cells, Dermatitis, Atopic, Hypersensitivity. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 38 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Introduction
Atopic dermatitis (AD), allergic rhinitis (AR), and bronchial asthma (BA) are major allergic diseases in childhood. Pediatric allergic diseases are characterized by the “atopic march,” where two or more allergic conditions can occur either simultaneously or sequentially. MicroRNAs (miRNAs) serve as fine regulators of gene expression, capable of modulating the clinical manifestations of allergic diseases posttranscriptionally. We investigated miRNAs commonly expressed in these three allergic diseases to enhance the understanding of their development and management.
Methods
We collected serum samples from subjects diagnosed with AD, AR, and BA as well as from healthy controls at Korea University Anam Hospital. Their miRNA expression patterns were analyzed using microarray technology. Additionally, we examined the allergic inflammatory response of miRNA through an allergic animal model.
Results
A total of 68 subjects were enrolled in the allergy group, consisting of 42 with AD, 13 with AR, and 13 with BA, while 10 children participated as controls. Microarray analysis revealed that miR-4497 expression levels were consistently downregulated in these three allergic disease groups. Following mast cell activation and miR-4497 transfection, reduced levels of macrophage-derived chemokines (MDCs) were observed. Furthermore, levels of IL-4, MDC, and methacholine Penh were significantly decreased in a miR-4497-treated mouse model.
Conclusions
MiR-4497 expressions were consistently downregulated in pediatric subjects with AD, AR, and BA. Allergic inflammation was significantly reduced in human mast cell-1 transfected with miR-4497 and in the treated mouse model. Further research is needed to elucidate the epigenetic mechanisms by which miR-4497 modulates allergic diseases and to explore its potential as a noninvasive biomarker for diagnosis and treatment.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pediatrics, Korea University College of Medicine, Seoul, Republic of Korea.
- Allergy Immunology Center, Korea University, Seoul, Republic of Korea.
Zitieren
APA
Yoo, Y., Lee, J. S., Park, Y., Han, C., Kim, S., Yoon, W., & Yoo, Y. (2025). MicroRNA-4497 Is Downregulated in Pediatric Allergic Diseases and Suppresses Th2 Inflammation in an Animal Model. International Archives of Allergy and Immunology. https://doi.org/10.1159/000545289
Vancouver
Yoo Y, Lee JS, Park Y, Han C, Kim S, Yoon W, et al. MicroRNA-4497 Is Downregulated in Pediatric Allergic Diseases and Suppresses Th2 Inflammation in an Animal Model. International Archives of Allergy and Immunology. 2025. doi:10.1159/000545289
BibTeX
@article{Yoo2025,
author = {Yoo, Young and Lee, Jue Seong and Park, Yongsung and Han, Changhak and Kim, Seunghyun and Yoon, Wonsuck and Yoo, Young},
title = {MicroRNA-4497 Is Downregulated in Pediatric Allergic Diseases and Suppresses Th2 Inflammation in an Animal Model},
journal = {International Archives of Allergy and Immunology},
year = {2025},
doi = {10.1159/000545289}
}
EUVIMED